Trial Details

Not Recruiting
Basic Information
Clinical ID c5611
Identifier NL-OMON42154
Trial Title Precision dosing of infliximab (IFX): the efficacy and economic effect of *precision dosing* of maintenance treatment with IFX in comparison with standard IFX maintenance treatment in inflammatory bowel disease. - Precision dosing of infliximab
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions IBD Inflammatory Bowel disease;10017969
Interventions Patients in the intervention arm will receive individualized treatment with variable IFX dosing AND/OR intervals guided by a Bayesian pharmacokinetic model, aiming to achieve an IFX TL of 3 mg/ml. Patients in the control group will continue
Participant Information
Sponsor Academisch Medisch Centrum
City NULL
Country/Region Netherlands
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement ADULT, ELDER, OLDER_ADULT
Study Design
Study Type Interventional
Phase NULL
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL